Anson Funds Management LP 13D/13G Filings for ZyVersa Therapeutics, Inc. (ZVSA)

Anson Funds Management LP 13D and 13G filings for ZyVersa Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
6:01 pm
Purchase
2024-09-30 13G ZyVersa Therapeutics, Inc.
ZVSA
Anson Funds Management LP 54,054
4.900%
54,054increase
(New Position)
Filing